Azerbaijan vs Colombia: Cause of death, by non-communicable diseases, ages 0-4
Azerbaijan
35.1%
in 2021
Colombia
35.2%
in 2021
Azerbaijan rank
74th
Colombia rank
73rd
Cause of death, by non-communicable diseases, ages 0-4 over time
- Azerbaijan
- Colombia
How they compare
Colombia currently reports 35.2% against 35.1% in Azerbaijan, a difference of 0.1%.
Across all 6 years both countries report, Colombia has been ahead every year.
Azerbaijan ranks 74th and Colombia ranks 73rd of 185 countries.
Colombia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Azerbaijan | Colombia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 11.5% | 22.7% | 11.2% | Colombia |
| 2010s | 25.5% | 34.5% | 9.0% | Colombia |
| 2020s | 34.8% | 34.9% | 0.2% | Colombia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 0-4, Azerbaijan or Colombia?
- Colombia, at 35.2% against 35.1% in Azerbaijan as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 0-4 between Azerbaijan and Colombia?
- 0.1%, with Colombia ahead.
- How many years of comparable data are there for Azerbaijan and Colombia?
- 6 years are reported by both, from 2000 to 2021.
- How do Azerbaijan and Colombia rank globally for cause of death, by non-communicable diseases, ages 0-4?
- Azerbaijan ranks 74th and Colombia ranks 73rd of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 0-4 (% of total deaths ages 0-4). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 0-4 due to non-communicable diseases divided by number of all deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.